Driehaus Capital Management LLC Elevation Oncology, Inc. Transaction History

Driehaus Capital Management LLC

  • $10.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.26 - $3.94 $1.98 Million - $6.19 Million
-1,571,509 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.34 - $6.41 $961,625 - $2.63 Million
-410,951 Reduced 20.73%
1,571,509 $3.96 Million
Q4 2021

Feb 14, 2022
SELL
$4.15 - $8.86 $62,681 - $133,821
-15,104 Reduced 0.76%
1,982,460 $11.9 Million
Q3 2021

Nov 15, 2021
SELL
$7.66 - $16.11 $14,937 - $31,414
-1,950 Reduced 0.1%
1,997,564 $15.6 Million
Q2 2021

Aug 16, 2021
BUY
$11.44 - $13.57 $22.9 Million - $27.1 Million
1,999,514 New
1,999,514 $26.5 Million

Others Institutions Holding ELEV

# of Institutions
68
Shares Held
45.4M
Call Options Held
700
Put Options Held
27.6K
View Full List

About Elevation Oncology, Inc.

ELEV Quotes by TradingView
  • Ticker ELEV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,300,900
  • Market Cap $14M
  • Description
  • Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...
More about ELEV
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email